MENA FOCUS 2026
Middle East Biomarkers Days: Molecular Biomarkers for Immuno-Oncology and Hematology & 2nd Frontiers of Combined Unique Solutions: ADCs and Bispecific Antibodies
at Hotel Douma
Date: 16th & 17th May, 2026
MENA FOCUS 2026
Middle East Biomarkers Days: Molecular Biomarkers for Immuno-Oncology and Hematology & 2nd Frontiers of Combined Unique Solutions: ADCs and Bispecific Antibodies
at Hotel Douma
Date: 16th & 17th May, 2026
Bioteckno participated in MENA Focus 2026, held on May 16 and 17 at Hotel Douma, bringing together oncology, hematology and molecular diagnostics experts from across the Middle East.
The conference highlighted advances in molecular biomarkers, Antibody-Drug Conjugates (ADCs), Bispecific Antibodies and innovative diagnostic solutions such as Idylla and NGS technologies.
Through expert-led sessions, panel discussions and networking opportunities, Bioteckno strengthened its position in oncology and molecular diagnostics, expanded potential partnerships with healthcare institutions and reinforced its contribution to innovation in cancer diagnosis and research.